Menactra is the latest vaccine for meningococcal meningitis

Menactra is the latest vaccine for meningococcal meningitis.

Think of Menactra as a new and improved Menomune.

Menomune provides immunity for only 3 to 5 years...Menactra immunity will likely last much longer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote